Axinn Promotes Bradley Justus to Partner, Dan Oakes and Jarod Taylor to Counsel
January 1, 2020
Axinn announced today that Bradley Justus, a member in the firm’s Antitrust group, has been promoted to partner. Dan Oakes, a member in the firm’s Antitrust group, and Jarod Taylor, a member in the firm’s Litigation group, have also been promoted to counsel. The promotions were effective as of January 1, 2020.
“Bradley, Dan, and Jarod are well-deserving of their promotions,” says Matthew Becker, Managing Partner of the firm. “Each of these extraordinarily talented lawyers are valued by our clients for their impressive legal skills and unique and innovative approaches. We congratulate each of them on their accomplishments so far and look forward to their continued contributions to Axinn and the legal community.”
Bradley Justus is based in the firm’s Washington, D.C. office and focuses his practice on antitrust law, including mergers, antitrust litigation, government investigations and counseling. He has significant experience in large global M&A transactions, appearing before the U.S. Department of Justice and Federal Trade Commission, in addition to representing clients in merger reviews by European, Brazilian, Canadian, and Mexican competition regulators.
Also based in the firm’s Washington, D.C. office, Dan Oakes focuses his practice on criminal antitrust investigation, antitrust litigation, merger analysis, and antitrust counseling. He has represented domestic and foreign corporate clients in international cartel investigations before the DOJ, the Canadian Competition Bureau, and European Commission. Dan also has significant experience leading merger, civil non-merger and other internal investigations.
Jarod Taylor, based in the firm’s Hartford office, has experience with litigation in federal courts across the country, as well as with arbitration and internal and governmental investigations. He has litigated cases involving contract disputes, business torts, patent infringement, and Fair, Reasonable And Non-Discriminatory (“FRAND”) licensing obligations.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Seven Axinn Attorneys Named to 2025 Capital Pro Bono Honor Roll
Pro Bono
Antitrust
Axinn Advises Thermo Fisher Scientific on $1.075 Billion Sale of its Microbiology Business to Astorg
Deals & Cases
Antitrust
Axinn Appoints Rachael Philbin as Chief Innovation Officer
News
Teva v. Lilly -- Clarifies Written Description of Method Claims Involving A Genus
Axinn Viewpoints
Intellectual Property
What’s Up? Competition Enforcement Updates From Italy and Portugal
Podcast
Antitrust
ACI 22nd Annual Paragraph IV Conference
Speaking Engagement
Intellectual Property
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
Antitrust Fault Lines: Will Licensing Negotiation Groups Reshape SEP Licensing?
Byline Articles
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
Kenina Lee Selected as a Member of Law360’s 2026 Competition Editorial Advisory Board
Awards & Recognitions
Antitrust